Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3640764
Max Phase: Preclinical
Molecular Formula: C10H14N2O
Molecular Weight: 178.24
Molecule Type: Small molecule
Associated Items:
ID: ALA3640764
Max Phase: Preclinical
Molecular Formula: C10H14N2O
Molecular Weight: 178.24
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NCC1CCC(c2cccnc2)O1
Standard InChI: InChI=1S/C10H14N2O/c11-6-9-3-4-10(13-9)8-2-1-5-12-7-8/h1-2,5,7,9-10H,3-4,6,11H2
Standard InChI Key: BZSFZSCNTDEVRV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 178.24 | Molecular Weight (Monoisotopic): 178.1106 | AlogP: 1.26 | #Rotatable Bonds: 2 |
Polar Surface Area: 48.14 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.48 | CX LogP: 0.36 | CX LogD: -1.68 |
Aromatic Rings: 1 | Heavy Atoms: 13 | QED Weighted: 0.74 | Np Likeness Score: 0.25 |
1. (2013) Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer, |
2. (2013) Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer, |
Source(2):